Kiora Pharmaceuticals KPRX
NASDAQ KPRX
$2.34 -0.01 (-0.43%)
As of: Oct 21, 2026 · 3:59 PM EDT

Kiora Pharmaceuticals (KPRX) Total Debt (2014 - 2021)

Updated

Kiora Pharmaceuticals (KPRX) reported Total Debt of $278,190 for Q1 2021, down 43.3% from the prior quarter.

Analysis

Kiora Pharmaceuticals (KPRX) Total Debt (2014 - 2021) Analysis & Trends

At the end of FY2020, Kiora Pharmaceuticals posted Total Debt of $490,471.

  • Five-year quarterly Total Debt spans a low of $278,190 in Q2 2020 and a high of $490,471 in Q4 2020.
  • Per Business Quant data, the three quarters before Q1 2021 came in at $490,471 (Q4 2020), $278,190 (Q3 2020) and $278,190 (Q2 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 49.04 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 70.82 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 32.35 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 26.25 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 63.19 Bn
10 Kiora Pharmaceuticals 14.34 Mn -52.98 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 278,190.00
Dec 31, 2020 490,471.00
Sep 30, 2020 278,190.00
Jun 30, 2020 278,190.00
Dec 31, 2014 3.21 Mn
API Access

Kiora Pharmaceuticals Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=KPRX&period=max&api_key=YOUR_API_KEY